Status: Recruiting
Preoperative Hemogram Parameters and BRAF Molecular Test Detected by Bethesda 3 Cytology.
The main hypothesis of this study is that preoperative hemogram parameters can be used as biomarkers for malignancy in patients with thyroid nodule Bethesda 3 cytology. The secondary hypothesis is that BRAF molecular testing has a high predictive value in predicting malignancy in patients with thyroid nodule Bethesda 3 cytology. Primary outcome: Preoperative hemogram parameters. Secondary outcome: BRAF positivity.
Participants needed: 120
Trial details
Age: 18-75Biological sex: AllType: ObservationalSponsor: Saglik Bilimleri UniversitesiUpdated: Aug 6, 2024Locations: 1Duration: 7 Days
Eligibility criteria
Patients between the ages of 18 -75 [+1]
Patients over 18 years old and under 75 years old [+3]